India's benchmark indexes are likely to open little changed on Tuesday, after logging their best day in more than four years ...

Indian pharma stocks fell 1.6% on Monday, bucking broader market gains, after U.S. President Trump said he would cut drug ...

(Reuters) -Indian pharmaceutical stocks shed 1.3% on Monday, even as the broader markets rose, after U.S. President Donald ...

Pharma stocks lit up Dalal Street on Tuesday as President Donald Trumps remarks on drug pricing sent mixed signals to global ...

Pharma stocks rise amid market drop due to limited impact from US pricing order. Discover more on what fuels this trend.

The sudden focus on pharmaceutical shares is due to a new executive order signed by US President Donald Trump on Monday.

US President Trump's move to cut drug prices by 30–80% may severely impact Indian pharma exports and profitability, ...

Indian pharmaceutical shares dropped up to 7% following US President Donald Trump's pledge to significantly lower US drug ...

Pharma stocks faced a downturn after US President Donald Trump revealed plans to slash drug prices. Sun Pharmaceuticals and ...

Trump said he would introduce a “most favoured nation” (MFN) policy whereby the US pays “the same price as the nation that ...

As the US government, under President Donald Trump, is on the verge of announcing significant new tariffs on pharmaceutical ...

Indian Pharma stocks were on a strong uptrend today, with the Nifty Pharma index rising by 1.19% in intraday trade.